fda declares semaglutide shortage resolved february 2025 Injections and the FDA Announces End to Semaglutide

En ensayos clnicos, los adultos mayores que tomaron tirzepatida tuvieron la misma probabilidad de sufrir cadas que quienes recibieron un placebo y menos probabilidades de fracturarse una costilla, la cadera, un brazo o una pierna

Abstracts from the 83rd Scientific Sessions of the American Diabetes Association

Semaglutide was compared with dulaglutide in patients with inadequately controlled type 2 diabetes in this open-label, parallel-group, phase 3b head-to-head trial

So, we chose to look at these two specifically among the other eight that also will have different sequel eyes or effect, if they are impacted with regards to the same observations that we gathered